These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33146155)

  • 1. Modelling the spread of SARS-CoV-2 pandemic - Impact of lockdowns & interventions.
    Agrawal M; Kanitkar M; Vidyasagar M
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):175-181. PubMed ID: 33146155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling of COVID-19 transmission: the roles of intervention strategies and lockdown.
    Bugalia S; Bajiya VP; Tripathi JP; Li MT; Sun GQ
    Math Biosci Eng; 2020 Sep; 17(5):5961-5986. PubMed ID: 33120585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic Landscape and Forecasting of SARS-CoV-2 in India.
    Rajendrakumar AL; Nair ATN; Nangia C; Chourasia PK; Chourasia MK; Syed MG; Nair AS; Nair AB; Koya MSF
    J Epidemiol Glob Health; 2021 Mar; 11(1):55-59. PubMed ID: 32959618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Ledinger D; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013574. PubMed ID: 33959956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in India: transmission dynamics, epidemiological characteristics, testing, recovery and effect of weather.
    Chanda A
    Epidemiol Infect; 2020 Aug; 148():e182. PubMed ID: 32778180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
    Pople D; Monk EJM; Evans S; Foulkes S; Islam J; Wellington E; Atti A; Hope R; Robotham J; Hopkins S; Brown CS; Hall VJ;
    BMJ; 2022 Jul; 378():e070379. PubMed ID: 35858689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the stringency of lockdown measures on covid-19: A theoretical model of a pandemic.
    Violato C; Violato EM; Violato EM
    PLoS One; 2021; 16(10):e0258205. PubMed ID: 34610042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of COVID-19: Impact of non-pharmaceutical interventions in India.
    Bajiya VP; Bugalia S; Tripathi JP
    Chaos; 2020 Nov; 30(11):113143. PubMed ID: 33261327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India.
    Patel P; Athotra A; Vaisakh TP; Dikid T; Jain SK;
    Indian J Public Health; 2020 Jun; 64(Supplement):S142-S146. PubMed ID: 32496246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach.
    Mandal S; Bhatnagar T; Arinaminpathy N; Agarwal A; Chowdhury A; Murhekar M; Gangakhedkar RR; Sarkar S
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):190-199. PubMed ID: 32362645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unprecedented reduction in air pollution and corresponding short-term premature mortality associated with COVID-19 lockdown in Delhi, India.
    Maji KJ; Namdeo A; Bell M; Goodman P; Nagendra SMS; Barnes JH; De Vito L; Hayes E; Longhurst JW; Kumar R; Sharma N; Kuppili SK; Alshetty D
    J Air Waste Manag Assoc; 2021 Sep; 71(9):1085-1101. PubMed ID: 33764280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.
    Davies NG; Kucharski AJ; Eggo RM; Gimma A; Edmunds WJ;
    Lancet Public Health; 2020 Jul; 5(7):e375-e385. PubMed ID: 32502389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting COVID-19 spread in the face of control measures in West Africa.
    Taboe HB; Salako KV; Tison JM; Ngonghala CN; Glèlè Kakaï R
    Math Biosci; 2020 Oct; 328():108431. PubMed ID: 32738248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.